Background Background Although recent
Although recent research has focused on the possible role research has focused on the possible role of antipsychotic medications in the of antipsychotic medications in the development of diabetes mellitus, studies development of diabetes mellitus, studies conducted in the pre-neuroleptic era conducted in the pre-neuroleptic era suggestthat schizophrenia itself might suggestthat schizophrenia itself might predispose individuals to diabetes. predispose individuals to diabetes.
Aims Aims To test the hypothesis that
To testthe hypothesis that diabetes mellitus is an integral part of diabetes mellitus is an integral part of schizophrenia. schizophrenia.
Method
Method Historical literature review.
Historicalliterature review.
Results
Results Many people with severe Many people with severe mental illnesses, including dementia mental illnesses, including dementia praecox, showed abnormal responses to praecox, showed abnormal responses to insulin and diabetes-like glucose tolerance insulin and diabetes-like glucose tolerance curves long before the advent of curves long before the advent of phenothiazines.Early studies with phenothiazines. Early studies with chlorpromazine suggested that a latent chlorpromazine suggested that a latent tendency towards diabetes in patients tendency towards diabetes in patients with schizophrenia could be unmasked by with schizophrenia could be unmasked by this treatment. this treatment.
Conclusions Conclusions Diabetes and disturbed
Diabetes and disturbed carbohydrate metabolism may be an carbohydrate metabolism may be an integral part of schizophrenia.Further integral part of schizophrenia.Further research is required to explain how research is required to explain how metabolic factors, medications and metabolic factors, medications and lifestyle factors might precipitate diabetes lifestyle factors might precipitate diabetes in patients with this mental disorder. in patients with this mental disorder.
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In recent decades medicine -especially psyIn recent decades medicine -especially psychiatry -has taken significant steps forward chiatry -has taken significant steps forward in understanding the biology, physiology and in understanding the biology, physiology and genetics of mental illness, and researchers genetics of mental illness, and researchers have gained a deeper understanding of the have gained a deeper understanding of the complexity of severe mental disorders and complexity of severe mental disorders and their possible association with medical contheir possible association with medical conditions. Psychopharmacology has expanded, ditions. Psychopharmacology has expanded, and this has contributed to more effective and this has contributed to more effective treatment of mental disorders and our treatment of mental disorders and our understanding of their underlying patholunderstanding of their underlying pathology. For more than half a century large ogy. For more than half a century large numbers of patients have received long numbers of patients have received long courses of psychotropic treatment, and the courses of psychotropic treatment, and the effects and side-effects of these medications effects and side-effects of these medications have gained prominence in both clinical have gained prominence in both clinical practice and academic circles. Extrapyramipractice and academic circles. Extrapyramidal side-effects, tardive dyskinesia, hyperdal side-effects, tardive dyskinesia, hyperprolactinaemia, weight gain, cardiotoxicity prolactinaemia, weight gain, cardiotoxicity and sexual dysfunction have all been assoand sexual dysfunction have all been associated with different classes of psychotropic ciated with different classes of psychotropic drugs, and although some of these effects drugs, and although some of these effects (hyperprolactinaemia and cardiotoxicity) (hyperprolactinaemia and cardiotoxicity) are clearly caused by the medication, other are clearly caused by the medication, other side-effects appear to be an integral part of side-effects appear to be an integral part of schizophrenia itself, and are only unmasked schizophrenia itself, and are only unmasked by psychotropic medications. by psychotropic medications.
Diabetes and schizophrenia have been Diabetes and schizophrenia have been linked since the beginning of the 20th linked since the beginning of the 20th century (Kooy, 1919; Raphael & Parsons, century (Kooy, 1919; Raphael & Parsons, 1921; Lorenz, 1922) , but the number of 1921; Lorenz, 1922) , but the number of new reports of an association between new reports of an association between diabetes and schizophrenia has alarmed diabetes and schizophrenia has alarmed clinicians in recent years. This has led to a clinicians in recent years. This has led to a revival of interest in this neglected area, revival of interest in this neglected area, and many new epidemiological studies and many new epidemiological studies and randomised controlled trials have been and randomised controlled trials have been conducted in an effort to redefine and conducted in an effort to redefine and clarify this association. clarify this association.
Research publications from 1919 onResearch publications from 1919 onwards were providing an insight into the wards were providing an insight into the association between diabetes and mental association between diabetes and mental illness long before the advent of psychotroillness long before the advent of psychotropic medication. These publications do not pic medication. These publications do not have the properties or reliability of modern have the properties or reliability of modern research, but they do draw attention to research, but they do draw attention to the association between schizophrenia the association between schizophrenia and diabetes without the interference of and diabetes without the interference of psychopharmacology. These publications psychopharmacology. These publications help us to answer two questions: whether help us to answer two questions: whether schizo schizophrenia is naturally associated with phrenia is naturally associated with diabetes diabetes without the precipitating effect without the precipitating effect of psychotropics, and whether conventional of psychotropics, and whether conventional neuroleptics such as the phenothiazines neuroleptics such as the phenothiazines have had an unmasking effect on have had an unmasking effect on diabetes in patients with a diagnosis of diabetes in patients with a diagnosis of schizophrenia. schizophrenia.
This paper provides a summary of case This paper provides a summary of case reports and publications on schizophrenia reports and publications on schizophrenia and diabetes dating from 1919 to the late and diabetes dating from 1919 to the late 1960s. Most of these are naturalistic com1960s. Most of these are naturalistic compilations of cases; they do not have the pilations of cases; they do not have the subtlety and refinement of modern statistisubtlety and refinement of modern statistical methodology, the reliability of complex cal methodology, the reliability of complex research designs, the power of randomised research designs, the power of randomised controlled trials, or the breadth of 21st-controlled trials, or the breadth of 21st-century epidemiological surveys. Most of century epidemiological surveys. Most of them cannot even boast clear diagnostic them cannot even boast clear diagnostic categories. Nevertheless, they are unique categories. Nevertheless, they are unique in the way they assist in eliminating the in the way they assist in eliminating the narrow psychopharmacological perspective narrow psychopharmacological perspective that may cloud the judgement of clinicians that may cloud the judgement of clinicians today, and help to broaden the current today, and help to broaden the current reductionist perspective. reductionist perspective.
METHOD METHOD
I carried out a review of the literature be-I carried out a review of the literature before and at the time of introduction of the fore and at the time of introduction of the phenothiazine antipsychotic medications. phenothiazine antipsychotic medications.
RESULTS RESULTS
Schizophrenia and diabetes Schizophrenia and diabetes in the pre-neuroleptic era in the pre-neuroleptic era As early as 1919, Kooy, in his long and As early as 1919, Kooy, in his long and detailed article, published the daily account detailed article, published the daily account and mental state of 10 patients with hebeand mental state of 10 patients with hebephrenic schizophrenia, and came to the phrenic schizophrenia, and came to the conclusion that their constant hyperglycaeconclusion that their constant hyperglycaemic curve meant that they had both demenmic curve meant that they had both dementia praecox and hyperglycaemia. Raphael tia praecox and hyperglycaemia. Raphael & Parsons (1921) studied blood glucose & Parsons (1921) studied blood glucose levels in 11 cases of dementia praecox and levels in 11 cases of dementia praecox and 11 cases of manic-depressive insanity: they 11 cases of manic-depressive insanity: they found pronounced initial hyperglycaemia found pronounced initial hyperglycaemia in both groups, and noted that in both groups, and noted that the glucose the glucose tolerance curves of both groups tolerance curves of both groups showed showed diabetic characteristics. diabetic characteristics.
Drury & Farron-Ridge (1921) looked Drury & Farron-Ridge (1921) looked at the blood glucose curves of a large group at the blood glucose curves of a large group of psychiatric in-patients and compared of psychiatric in-patients and compared these with the curves of patients with these with the curves of patients with dementia praecox and manic depression. dementia praecox and manic depression. They concluded that the curves in the They concluded that the curves in the dementia praecox patients varied greatly dementia praecox patients varied greatly from the accepted norms and that, in many from the accepted norms and that, in many s 6 4 s 6 4
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cases, general metabolism is far more cases, general metabolism is far more disordered in insanity than one would be disordered in insanity than one would be led to believe by casual observations. They led to believe by casual observations. They also noted many cases where 'the blood also noted many cases where 'the blood sugar metabolism would appear to be sugar metabolism would appear to be normal but it is in fact greatly upset' and normal but it is in fact greatly upset' and that 'confusion and melancholia are assothat 'confusion and melancholia are associated with the greatest disturbance of ciated with the greatest disturbance of sugar metabolism' (Drury & Farron-Ridge, sugar metabolism' (Drury & Farron-Ridge, 1921 ). 1921 . Lorenz (1922) reported that some of his Lorenz (1922) reported that some of his patients with catatonic dementia praecox patients with catatonic dementia praecox responded to glucose feeding with hyperresponded to glucose feeding with hyperglycaemic curves. He also noticed that his glycaemic curves. He also noticed that his catatonic and stuporous patients fared even catatonic and stuporous patients fared even worse in their hyperglycaemic curves. worse in their hyperglycaemic curves. Barrett & Serre (1924) found an excess of Barrett & Serre (1924) found an excess of sugar intolerance related to psychosis and sugar intolerance related to psychosis and manic depression. Thirty of their patients manic depression. Thirty of their patients with dementia praecox had glucose tolwith dementia praecox had glucose tolerance curves similar to patients with erance curves similar to patients with diabetes. These investigators also found diabetes. These investigators also found fluctuations in repeated tests, but could fluctuations in repeated tests, but could not establish a curve typical for both psynot establish a curve typical for both psychiatric conditions. In 1925, Henry & chiatric conditions. In 1925, Henry & Mangan studied nine patients in acute Mangan studied nine patients in acute stages of dementia praecox, and noted that stages of dementia praecox, and noted that their glucose tolerance curves indicated a their glucose tolerance curves indicated a definite 'retardation' in glucose metabolism definite 'retardation' in glucose metabolism (Henry & Mangan, 1925) . Kasanin (1926) (Henry & Mangan, 1925) . Kasanin (1926) studied the blood glucose curves in a group studied the blood glucose curves in a group of patients with dementia praecox. In his of patients with dementia praecox. In his cohort of 33 individuals, 22 had abnormal cohort of 33 individuals, 22 had abnormal curves, and he concluded that these patients curves, and he concluded that these patients had a derangement of carbohydrate metahad a derangement of carbohydrate metabolism. He also collected from the literabolism. He also collected from the literature accounts of 154 patients with ture accounts of 154 patients with dementia praecox and abnormal blood gludementia praecox and abnormal blood glucose curves, and concluded that abnormal cose curves, and concluded that abnormal blood glucose levels were seen more blood glucose levels were seen more frequently in patients with dementia praefrequently in patients with dementia praecox than in normal populations. cox than in normal populations.
Freeman Freeman et al et al (1944) studied the carbo-(1944) studied the carbohydrate tolerance of 91 soldiers with psyhydrate tolerance of 91 soldiers with psychiatric diagnoses and 20 normal controls. chiatric diagnoses and 20 normal controls. In this series, psychiatric patients had In this series, psychiatric patients had higher blood glucose levels 60 min followhigher blood glucose levels 60 min following oral glucose ingestion than the normal ing oral glucose ingestion than the normal group. Abnormal glucose tolerance curves group. Abnormal glucose tolerance curves were found in 31% of his psychiatric were found in 31% of his psychiatric patients. patients.
Schizophrenia and insulin Schizophrenia and insulin coma therapy coma therapy
In the first decades of the 20th century, In the first decades of the 20th century, insulin-induced hypoglycaemic coma therinsulin-induced hypoglycaemic coma therapy was thought to relieve patients from apy was thought to relieve patients from symptoms of schizophrenia. Insulin coma symptoms of schizophrenia. Insulin coma therapy units were set up in many hospitals therapy units were set up in many hospitals and asylums in the 1940s and 1950s. This and asylums in the 1940s and 1950s. This brutal and ineffective treatment method, brutal and ineffective treatment method, based on producing coma by injecting high based on producing coma by injecting high doses of insulin repeatedly until convuldoses of insulin repeatedly until convulsions occurred, was used widely for almost sions occurred, was used widely for almost three decades. While this therapy was in three decades. While this therapy was in use, it came to the attention of clinicians use, it came to the attention of clinicians that there was an abnormal response to that there was an abnormal response to insulin in patients with schizophrenia cominsulin in patients with schizophrenia compared with people without this illness pared with people without this illness (Appel & Farr, 1929) . Freeman (Appel & Farr, 1929) . Freeman et al et al (1943) studied the effects of insulin on gly-(1943) studied the effects of insulin on glycaemia in 32 male patients with schizocaemia in 32 male patients with schizophrenia and 20 normal controls. They phrenia and 20 normal controls. They noted that 41% of patients showed 'greater noted that 41% of patients showed 'greater resistiveness' and 'less responsivity' to insuresistiveness' and 'less responsivity' to insulin than did normal individuals. One year lin than did normal individuals. One year later, these investigators also noted less prolater, these investigators also noted less pronounced reductions in blood glucose levels nounced reductions in blood glucose levels following the administration of insulin following the administration of insulin compared with a normal control group, compared with a normal control group, and they concluded that these results sugand they concluded that these results suggested a need for further investigation into gested a need for further investigation into 'carbohydrate metabolism of the central 'carbohydrate metabolism of the central nervous system in cases of this psychosis' nervous system in cases of this psychosis' (Freeman (Freeman et al et al, 1944 (Freeman et al et al, ). , 1944 . This resistance to a lowering of blood This resistance to a lowering of blood sugar following insulin injection was replisugar following insulin injection was replicated by Braceland cated by Braceland et al et al (1945) , who noted (1945), who noted diabetic-like glucose tolerance curves and diabetic-like glucose tolerance curves and the delayed response to insulin. the delayed response to insulin.
Phenothiazines and the emergence Phenothiazines and the emergence of diabetes mellitus of diabetes mellitus
Following the introduction of chlorpromaFollowing the introduction of chlorpromazine in 1952, a further series of diabetes zine in 1952, a further series of diabetes case reports were published. The first case reports were published. The first report came from Courvoisier report came from Courvoisier et al et al (1953 Courvoisier et al et al ( ). (1953 . Dobkin Dobkin et al et al (1954) designed a study in (1954) designed a study in which they injected chlorpromazine which they injected chlorpromazine 1.5 mg/kg into seven normal volunteers, 1.5 mg/kg into seven normal volunteers, and found them to respond with increased and found them to respond with increased blood glucose levels. Giacobini & Lassenius blood glucose levels. Giacobini & Lassenius (1954) Charatan & Bartlett (1955) studied the Charatan & Bartlett (1955) studied the effects of chlorpromazine on glucose tolereffects of chlorpromazine on glucose tolerance in 11 patients with schizophrenia ance in 11 patients with schizophrenia (seven women and four men, mean age (seven women and four men, mean age 30.3 years) who were all on a hospital diet. 30.3 years) who were all on a hospital diet. Before chlorpromazine treatment, it was esBefore chlorpromazine treatment, it was established that they all had normal glucose tablished that they all had normal glucose tolerance curves. After treatment with tolerance curves. After treatment with intravenous chlorpromazine, patients were intravenous chlorpromazine, patients were given a single loading dose of 50 g glucose. given a single loading dose of 50 g glucose. Results indicated 'a pronounced delay in the Results indicated 'a pronounced delay in the removal of glucose from blood' (Charatan removal of glucose from blood' (Charatan & Bartlett, 1955 (1966) surveyed 359 men under the age of 50 years with severe mental illness age of 50 years with severe mental illness living in a mental hospital. He discovered living in a mental hospital. He discovered that 11.7% of the men had previously that 11.7% of the men had previously unknown diabetes, and concluded that unknown diabetes, and concluded that diabetes rates were higher in patients with diabetes rates were higher in patients with schizophrenia than in the normal popuschizophrenia than in the normal population. However, his reports do not make lation. However, his reports do not make it clear how many of these patients had it clear how many of these patients had been treated with psychotropic medication. been treated with psychotropic medication. Winkelmayer (1962) surveyed 798 male Winkelmayer (1962) surveyed 798 male in-patients in the New Jersey State Hospital in-patients in the New Jersey State Hospital in Marlboro for the presence of diabetes in Marlboro for the presence of diabetes mellitus and chronic renal disease. He mellitus and chronic renal disease. He noted that the high percentage of people noted that the high percentage of people with diabetes in the group of patients with with diabetes in the group of patients with schizophrenia suggested that this group schizophrenia suggested that this group 'could have a greater predilection toward 'could have a greater predilection toward the development of diabetes mellitus than the development of diabetes mellitus than the average individuals'. He also noted that the average individuals'. He also noted that the average period of hospitalisation before the average period of hospitalisation before detection of diabetes was 25 years, and detection of diabetes was 25 years, and stressed the importance of surveys for stressed the importance of surveys for detecting patients with unknown diabetes detecting patients with unknown diabetes among the long-term residents of large among the long-term residents of large mental hospitals. mental hospitals. Korenyi & Lowenstein (1968 ) investiKorenyi & Lowenstein (1968 investigated two patients with altered glucose megated two patients with altered glucose metabolism associated with chlorpromazine, tabolism associated with chlorpromazine, and noted that upon withdrawal of the and noted that upon withdrawal of the drug, one patient remained diabetic while drug, one patient remained diabetic while the second patient returned to normal. the second patient returned to normal. Dynes (1969) compared 22 patients Dynes (1969) compared 22 patients with diabetes with 33 patients with both with diabetes with 33 patients with both schizophrenia and diabetes, and concluded schizophrenia and diabetes, and concluded that phenothiazines might have precipitated that phenothiazines might have precipitated a latent diabetic tendency into full-blown a latent diabetic tendency into full-blown diabetes mellitus in the latter group. He diabetes mellitus in the latter group. He commented that patients with schizocommented that patients with schizophrenia were more likely to have a family phrenia were more likely to have a family history of diabetes, and that such patients history of diabetes, and that such patients were more likely to show signs of obesity were more likely to show signs of obesity due to their altered physiological response. due to their altered physiological response.
Keskiner Keskiner et al et al (1973) studied 249 pa-(1973) studied 249 patients, the majority of whom had a diagtients, the majority of whom had a diagnosis of schizophrenia, and found that a nosis of schizophrenia, and found that a quarter (25.7%) also had diabetes. The quarter (25.7%) also had diabetes. The mean age of the patients was 48.9 years mean age of the patients was 48.9 years s 6 5 s 6 5 and the mean duration in hospital was 16.5 and the mean duration in hospital was 16.5 years. These investigators concluded that years. These investigators concluded that there was a higher incidence there was a higher incidence of diabetes of diabetes mellitus in patients treated with psychotromellitus in patients treated with psychotropic drugs. They also recognised that unpic drugs. They also recognised that undiagnosed diabetes in psychiatric patients diagnosed diabetes in psychiatric patients receiving chemotherapy presented a new receiving chemotherapy presented a new challenge to clinicians. challenge to clinicians.
DISCUSSION DISCUSSION
Case studies and thoughtful naturalistic Case studies and thoughtful naturalistic publications prior to the availability of publications prior to the availability of phenothiazines, albeit poor in design, still phenothiazines, albeit poor in design, still help the modern clinician to ask valid help the modern clinician to ask valid questions and gain an insight into possible questions and gain an insight into possible pathological conditions associated with pathological conditions associated with schizophrenia. They raise the intriguing schizophrenia. They raise the intriguing possibility that diabetes and disturbed possibility that diabetes and disturbed carbohydrate metabolism could be an carbohydrate metabolism could be an integral part of the schizophrenia disease integral part of the schizophrenia disease process. process.
Even in historical publications, schizoEven in historical publications, schizophrenia seems to be associated with higher phrenia seems to be associated with higher rates of diabetes. Research today is focusing rates of diabetes. Research today is focusing on trying to explain how psychotropic medon trying to explain how psychotropic medications, lifestyle and other metabolic facications, lifestyle and other metabolic factors could possibly precipitate or unmask tors could possibly precipitate or unmask diabetes in people with schizophrenia. diabetes in people with schizophrenia. Courvoisier, S., Fournel, J., Ducrot, R., Courvoisier, S., Fournel, J., Ducrot, R., et al et al (1953) (1953) Pharmacodynamic properties of 3-chloro-10 -(3-Pharmacodynamic properties of 3-chloro-10 -(3-dimethylaminopropyl)-phenothiazine hydrochloride dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation. in potentialized anesthesia and in artificial hibernation. 
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